One Year Later, Testing Remains Important
April 19 2021 - 9:00AM
Business Wire
Walmart’s Julie Barber, Senior Vice President of Health &
Wellness Merchandising released the following note Monday:
“One year ago, I was leading the testing rollout for our
associates as the pandemic brought us so many unknowns, but our
goal was to keep our associates and customers informed, healthy and
safe. Now, one year later, we have COVID-19 vaccines available and
nearly 200 million Americans have received at least one shot; we
know face coverings help prevent the spread; and we know testing
still remains important.
“Testing, whether at community testing sites or providers, is
crucial to tell if individuals are infected to help keep our
communities safe, allow us to travel and to hug and see loved ones
while still following CDC guidance to keep ourselves and others
safe. There also are multiple, authorized home test kits available,
making testing even more convenient and accessible.
“I am excited that today we are adding the BinaxNOW COVID-19
Antigen Self Test to the assortment we are selling on Walmart.com
and in stores now for $19.88 for the kit. This test, which is
packaged in a kit with two tests per box, is intended for testing
twice over three days via nasal swab with at least 36 hours between
tests. The test detects proteins from the virus that causes
COVID-19. This kit delivers results in 15 minutes.
“Today, Walmart continues to play a vital role in helping reopen
the country and end the pandemic. We are administering COVID-19
vaccines in more than 5,100 locations in 51 jurisdictions, and we
are supporting more than 500 testing sites across the country that
have tested hundreds of thousands of people. From the day we were
first asked, and it was apparent testing was a key element in the
fight to combat the pandemic, our goal was to help provide
increased access to testing in our communities. We continue to find
innovative ways to do just that, and this is just one more way we
continue to play a role in the health of our communities.”
The BinaxNOW™ COVID-19 Antigen Self Test has not been FDA
cleared or approved. It has been authorized by the FDA under an
emergency use authorization. It has been authorized only for the
detection of proteins from SARS-CoV-2, not for any other viruses or
pathogens, and is only authorized for the duration of the
declaration that circumstances exist justifying the authorization
of emergency use of in vitro diagnostics for detection and/or
diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food,
Drug and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the
declaration is terminated or authorization is revoked sooner.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210419005291/en/
Marilee McInnis 800-331-0085
Walmart (NYSE:WMT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Walmart (NYSE:WMT)
Historical Stock Chart
From Sep 2023 to Sep 2024